SARS-CoV-2 special risk groups: aged care residents and workers with Professor Robert Booy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b5/51/e7/b551e72b-bc7a-a10a-b90a-95f919c6b41a/mza_10872013384498953585.jpg/600x600bb.jpg

COVID19 Road to a vaccine

MVEC

18 episodes

8 months ago

The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.

Medicine

Health & Fitness

RSS

All content for COVID19 Road to a vaccine is the property of MVEC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/89a7f3d037c7a3c66e8b53401be97e50.jpg

SARS-CoV-2 special risk groups: aged care residents and workers with Professor Robert Booy

COVID19 Road to a vaccine

20 minutes

5 years ago

SARS-CoV-2 special risk groups: aged care residents and workers with Professor Robert Booy

In episode 9 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks with Professor Robert Booy. Robert is a Professor of Paediatrics and Child Health at the University of Sydney and is a Senior Professorial Fellow at NCIRS, the National Centre for Immunisation Research and Surveillance at Westmead Children’s Hospital. He has special research interests in serious infections and their prevention, particularly in the setting of aged care facilities. In this episode they discuss:

•Special risk groups when it comes to SARS-CoV-2, in particular, those living and working in aged care facilities
•How the ageing process leads to immunosenescence and the impact of this on vaccine efficacy in the elderly population
•The use of adjuvants in vaccines for the elderly population
•How to improve public health messaging and the management of respiratory illnesses in aged care facilities
•Lessons learnt from around the world with high mortality rates in aged care residents and workers and how that can inform the response to outbreaks in aged care facilities in Australia

Links:

The Conversation: Protecting our elderly: beating flu outbreaks in nursing homes
https://theconversation.com/protecting-our-elderly-beating-flu-outbreaks-in-nursing-homes-2960

The Guardian: National cabinet plans rapid-response units to curb COVID-19 outbreaks in Australian aged care facilities
https://www.theguardian.com/australia-news/2020/aug/07/national-cabinet-plans-rapid-response-units-to-curb-covid-19-outbreaks-in-australian-aged-care-facilities?CMP=Share_iOSApp_Other

PLOS One: Treating and Preventing Influenza in Aged Care Facilities: A Cluster Randomised Controlled Trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474842/